Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Receivables (2020 - 2025)

Historic Receivables for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Celularity's Receivables fell 2354.62% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 2354.62%. This contributed to the annual value of $13.6 million for FY2024, which is 3494.92% up from last year.
  • Per Celularity's latest filing, its Receivables stood at $6.7 million for Q3 2025, which was down 2354.62% from $11.2 million recorded in Q2 2025.
  • Celularity's 5-year Receivables high stood at $15.0 million for Q1 2025, and its period low was $1.8 million during Q3 2021.
  • In the last 5 years, Celularity's Receivables had a median value of $4.5 million in 2022 and averaged $7.3 million.
  • Per our database at Business Quant, Celularity's Receivables plummeted by 2850.24% in 2023 and then skyrocketed by 37908.96% in 2024.
  • Celularity's Receivables (Quarter) stood at $2.7 million in 2021, then surged by 62.19% to $4.5 million in 2022, then skyrocketed by 125.65% to $10.0 million in 2023, then surged by 34.95% to $13.6 million in 2024, then tumbled by 50.54% to $6.7 million in 2025.
  • Its last three reported values are $6.7 million in Q3 2025, $11.2 million for Q2 2025, and $15.0 million during Q1 2025.